Creative Biolabs Oncolytic Virotherapy

Menu

Skip to content
  • Oncolytic Virus Research
  • Oncolytic Virus News

Monthly Archives: November 2023

18Nov/23

Research Reveals New Mechanism of Oncolytic Virus M1 Enhancing DC Vaccine’s Anti-Tumor Effect

November 18, 2023Oncolytic Virus News, Oncolytic Virus ResearchDC Vaccine, Oncolytic Virusbiolabs

Immunotherapy has garnered significant attention due to its potential in achieving long-term control of tumor progression and extending the survival of patients in cancer treatment. Dendritic cells (DCs), known as the mostRead More…

Recent Posts

  • Combining Oncolytic Viruses with T-cell Therapy Enhances Cancer Treatment
  • Swine Pseudorabies Virus Attenuated Vaccine Shows Potential for Oncolytic Therapy Against Malignant Tumors
  • Oncolytic Virus Therapy CAN-3110 Shows Promise in Treating Aggressive Brain Cancer Glioblastoma
  • Research Reveals New Mechanism of Oncolytic Virus M1 Enhancing DC Vaccine’s Anti-Tumor Effect
  • Oncolytic Viruses Can Induce A “Cold” Tumor to Heat Up and Improve the Efficiency of Immunotherapy in Treating Cancer

Archives

  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • November 2020

Contact Us

USA – UK

Copyright © Creative Biolabs Oncolytic Virotherapy
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Oncolytic Virus Research
  • Oncolytic Virus News